BOSTON & GENEVA--(PHT Corporation announced a 36% increase in revenues in the first half of 2012 over the same period last year, with bookings increasing 27%. Global headcount expanded by 29%, allowing PHT to continue to support growth.)--
“PHT is experiencing phenomenal growth for two key reasons: The ePRO/eCOA market is growing as sponsors and regulators are demanding more high quality patient-driven eData in clinical research; and, PHT is focused on delivering innovative solutions that solve real problems for customers.”
PHT added 9 new sponsors and CROs to its client roster as leading biopharmaceutical companies selected PHT’s electronic clinical outcome assessment (eCOA) systems for use in 37 new clinical trials over the first half of the year. In addition to using the device-based LogPad® and SitePad® Systems, clinical trials also are underway with PHT’s NetPRO™ Web browser-based system.
PHT President and CEO Philip Lee said, “PHT is experiencing phenomenal growth for two key reasons: The ePRO/eCOA market is growing as sponsors and regulators are demanding more high quality patient-driven eData in clinical research; and, PHT is focused on delivering innovative solutions that solve real problems for customers.”
Driving PRO & ePRO Innovation – PHT released StudyWorks® 4.16, the latest version of its unique online clinical patient data reporting portal with features including intuitive dashboards and faster performance for increased site satisfaction.
National Recognition – PHT’s Phil Lee was a finalist for the New England Region Ernst & Young Entrepreneur Of The Year® 2012 Award which recognized outstanding entrepreneurs who demonstrate excellence and extraordinary success and commitment to their businesses and communities. Additionally, PHT was named one of New England’s fastest growing private companies by the Boston Business Journal and Inc. Magazine.
Advancing ePRO Adoption –The Annual PRO & ePRO Congress in Annecy, France attracted experts from the sponsor, CRO, clinician and regulatory communities. Attendees engaged in lively and informative discussions on how to effectively advance the use of eData Systems to collect and manage patient driven outcomes. Congress sponsors included SCRIP Clinical Research, Lionbridge Technologies Inc., Bluebird Soft Inc., and GIGABYTE Technology Company. Additionally, at DIA 2012, PHT Founder Dr. Stephen Raymond and Europe General Manager Valdo Arnera, MD addressed the impact of eClinical technology innovation on Biopharmaceuticals, CROs and patients.
PHT’s Vice President of Marketing and Product Management Sheila Rocchio added, “Sponsors choose PHT because we are the largest, most experienced, and most financially stable provider of patient-driven eData systems. We turn our previous clinical, operational, and regulatory experiences into tangible benefits that reduce risk and build confidence at every phase of the trial process.”
About PHT Corporation
PHT Corporation helps biopharmaceutical companies and CROs conduct clinical studies with greater confidence, ease and accuracy. We enable our clients to gain insights, through measuring how patients feel and function, that help speed therapies to market and improve lives. From our 500+ global trial experiences including 16 regulatory approvals, we offer the breadth, history and scientific expertise today’s market demands. PHT's proven Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via StudyWorks® online portal, provides sponsors and clinicians with a real-time window to patients between visits for improved protocol compliance and safety monitoring. For more information on Patient Driven eData, eCOA and ePRO, review the interactive content and demonstrations at phtcorp.com. Follow PHT on Twitter@PHT ePRO.
PHT, LogPad, SitePad and StudyWorks are registered trademarks of PHT Corporation. NetPRO is a trademark of PHT Corporation.